Putative role of neuronal 5-lipoxygenase in an aging brain

被引:95
作者
Manev, H [1 ]
Uz, T [1 ]
Sugaya, K [1 ]
Qu, TY [1 ]
机构
[1] Univ Illinois, Inst Psychiat, Dept Psychiat, Chicago, IL 60612 USA
关键词
5-LOX; aged-associated CNS alterations; neuronal degeneration; cyclooxygenase; COX;
D O I
10.1096/fj.14.10.1464
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aging is associated with increased incidence and/or severity of neurodegenerative pathologies. Oxygen-mediated events are being considered as possible mechanisms responsible for the increasing neuronal vulnerability. Lipoxygenases are enzymes that, as cyclooxygenases (COX), can insert oxygen into the molecule of arachidonic acid and thereby synthesize inflammatory eicosanoids: leukotrienes [due to 5-lipoxygenase (5-LOX) activity] and prostaglandins (via COX activity), It appears that 5-LOX is expressed in central nervous system neurons and may participate in neurodegeneration. 5-LOX-triggered cell death may be initiated by the enzymatic activity of 5-LOX but could also occur via the nonenzymatic actions of the 5-LOX protein; new data point to the possibility that 5-LOX protein exerts actions such as interaction with tyrosine kinase receptors, cytoskeletal proteins, and the nucleus. The expression of neuronal 5-LOX is susceptible to hormonal regulation, presumably due to the presence of hormone-responsive elements in the structure of the 5-LOX gene promoter. The expression of the 5-LOX gene and the activity of the 5-LOX pathway are increased in elderly subjects. One possible mechanism of such 5-LOX up-regulation implies the contribution of aging-associated hormonal changes: relative melatonin deficiency and/or hyperglucocorticoidemia. Thus, the 5-LOX pathway could become a promising target of neuroprotective therapies for the aging brain.
引用
收藏
页码:1464 / 1469
页数:6
相关论文
共 62 条
[1]  
[Anonymous], J ANTIAGING MED, DOI DOI 10.1089/rej.1.1999.2.15
[2]   THE CYCLOOXYGENASE AND LIPOXYGENASE INHIBITOR BW755C PROTECTS RATS AGAINST KAINIC ACID-INDUCED SEIZURES AND NEUROTOXICITY [J].
BARAN, H ;
VASS, K ;
LASSMANN, H ;
HORNYKIEWICZ, O .
BRAIN RESEARCH, 1994, 646 (02) :201-206
[3]   Regulation of expression of the 5-lipoxygenase pathway [J].
Bigby, TD .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 1999, 17 (1-2) :43-58
[4]   Emerging roles for SH2/PTB-containing Shc adaptor proteins in the developing mammalian brain [J].
Cattaneo, E ;
Pelicci, PG .
TRENDS IN NEUROSCIENCES, 1998, 21 (11) :476-481
[5]  
Chakraborti T, 1999, BIOCHEM MOL BIOL INT, V47, P501
[6]   Determinants of 5-lipoxygenase nuclear localization using green fluorescent protein 5-lipoxygenase fusion proteins [J].
Chen, XS ;
Zhang, YY ;
Funk, CD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (47) :31237-31244
[7]   Opioids, NSAIDs and 5-lipoxygenase inhibitors act synergistically in brain via arachidonic acid metabolism [J].
Christie, MJ ;
Vaughan, CW ;
Ingram, SL .
INFLAMMATION RESEARCH, 1999, 48 (01) :1-4
[8]   Polyunsaturated fatty acids activate the Drosophila light-sensitive channels TRP and TRPL [J].
Chyb, S ;
Raghu, P ;
Hardie, RC .
NATURE, 1999, 397 (6716) :255-259
[9]   The PPAR alpha-leukotriene B-4 pathway to inflammation control [J].
Devchand, PR ;
Keller, H ;
Peters, JM ;
Vazquez, M ;
Gonzalez, FJ ;
Wahli, W .
NATURE, 1996, 384 (6604) :39-43
[10]   Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment [J].
Drazen, JM ;
Yandava, CN ;
Dubé, L ;
Szczerback, N ;
Hippensteel, R ;
Pillari, A ;
Israel, E ;
Schork, N ;
Silverman, ES ;
Katz, DA ;
Drajesk, J .
NATURE GENETICS, 1999, 22 (02) :168-170